Healthcare / Medical Care FacilitiesStockholm
$139.00
-6.30 (-4.34%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.9B · quality 62.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
47/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$11.2B
P/E
16.3x
↓EV/EBITDA
8.5x
↓ROE
12.8%
↑Gross Margin
96.5%
↑Debt/Equity
2.43
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+8.3%
FCF CAGR
+15.0%
FCF margin
12.7%
FCF / Net income
3.05x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $16.04B · net income $665.0M · FCF $2.03B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $16.04B | $16.04B | $14.20B | $13.31B | $12.63B |
| Net Income | $665.0M | $665.0M | $620.0M | $455.0M | $366.0M |
| EBITDA | $2.85B | $2.85B | $2.62B | $2.25B | $2.00B |
| EPS | 7.92 | 7.92 | 7.20 | 5.07 | 3.89 |
| Gross Margin | 96.5% | 96.5% | 96.5% | 96.5% | 96.5% |
| Operating Margin | 8.5% | 8.5% | 8.8% | 7.3% | 6.7% |
| Net Margin | 4.1% | 4.1% | 4.4% | 3.4% | 2.9% |
| Balance Sheet | |||||
| Debt/Equity | 2.43 | 2.43 | 2.16 | 2.18 | 2.34 |
| Current Ratio | 0.45 | 0.45 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.03B | $2.03B | $1.95B | $1.62B | $1.33B |
| Returns | |||||
| ROE | 12.8% | 12.8% | 12.4% | 9.2% | 7.8% |
| Valuation | |||||
| P/E | 16.28 | 16.28 | 13.73 | 10.42 | 11.19 |
| EV/EBITDA | 8.50 | 8.50 | 7.35 | 6.88 | 7.39 |
| P/B | 2.24 | 2.24 | 1.71 | 0.96 | 0.88 |
| Growth & Yield | |||||
| Revenue Growth | 13.0% | 13.0% | 6.6% | 5.4% | — |
| EPS Growth | 10.0% | 10.0% | 42.0% | 30.3% | — |
| Dividend Yield | 1.8% | 1.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
15.9%
EPS terminal req.
$12.33
Spread vs growth
-5.9%
5Y implied EPS CAGR
13.5%
EPS terminal req.
$14.92
Spread vs growth
-3.5%
10Y implied EPS CAGR
11.7%
EPS terminal req.
$24.04
Spread vs growth
-1.7%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+30.2%
Start / end P/E
15.0x → 17.6x
EPS bridge
7.20 → 7.92
Residual
+1.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.